Stem cell-mediated natural tissue engineering

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 1, 2011, Pages 52-62

  Mollmann H ^a   Nef, H M ^a   Voss, S ^a   Troidl, C ^a   Willmer, M ^a   Szardien, S ^a   Rolf, A ^a   Klement, M ^a   Voswinckel, R ^a   Kostin, S ^b   Ghofrani, H A ^a   Hamm, C W ^a   Elsasser A ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Angiogenesis; Cardiac tissue engineering; Molecular biology; Myocardium

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; ENZYME IMMUNOASSAY; FIBROBLAST; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; METABOLISM; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; SWINE; TISSUE ENGINEERING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; FIBROBLASTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; IMMUNOENZYME TECHNIQUES; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; TISSUE ENGINEERING; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA;

EID: 78751687089     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00972.x     Document Type: Article

References (34)

1. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature. 2008; 453: 322-9.
2. Orlic D, Kajstura J, Chimenti S, et al Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410: 701-5.
3. Orlic D, Kajstura J, Chimenti S, et al Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 2001; 98: 10344-9.
4. Mollmann H, Nef HM, Kostin S, et al Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res. 2006; 71: 661-71.
5. Balsam LB, Wagers AJ, Christensen JL, et al Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428: 668-73.
6. Murry CE, Soonpaa MH, Reinecke H, et al Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428: 664-8.
7. Schachinger V, Erbs S, Elsasser A, et al Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355: 1210-21.
8. Sussman MA, Murry CE. Bones of contention: marrow-derived cells in myocardial regeneration. J Mol Cell Cardiol. 2008; 44: 950-3.
9. Elsasser A, Mollmann H, Nef H, et al Transcatheter closure of a ruptured ventricular septum after myocardial infarction using a venous approach. Z Kardiol. 2005; 94: 684-9.
10. Mollmann H, Nef HM, Kostin S, et al Images in cardiovascular medicine. Natural tissue engineering inside a ventricular septum defect occluder. Circulation. 2006; 113: e718-9.
11. Kessinger A, Sharp JG. Mobilization of blood stem cells. Stem Cells. 1998; 16: 139-43.
12. Schiller NB, Shah PM, Crawford M, et al Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-67.
13. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: 2002-7.
14. van Amerongen MJ, Harmsen MC, Petersen AH, et al The enzymatic degradation of scaffolds and their replacement by vascularized extracellular matrix in the murine myocardium. Biomaterials. 2006; 27: 2247-57.
15. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008; 20: 86-100.
16. Obermeyer N, Janson N, Bergmann J, et al Proteome analysis of migrating versus nonmigrating rat heart endothelial cells reveals distinct expression patterns. Endothelium. 2003; 10: 167-78.
17. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001; 2: REVIEWS3005.
18. Amann K, Faulhaber J, Campean V, et al Impaired myocardial capillarogenesis and increased adaptive capillary growth in FGF2-deficient mice. Lab Invest. 2006; 86: 45-53.
19. Durocher D, Charron F, Warren R, et al The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J. 1997; 16: 5687-96.
20. Svensson EC, Tufts RL, Polk CE, et al Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytes. Proc Natl Acad Sci USA. 1999; 96: 956-61.
21. Molkentin JD, Kalvakolanu DV, Markham BE. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol Cell Biol. 1994; 14: 4947-57.
22. Grepin C, Dagnino L, Robitaille L, et al A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol. 1994; 14: 3115-29.
23. Thuerauf DJ, Hanford DS, Glembotski CC. Regulation of rat brain natriuretic peptide transcription. A potential role for GATA-related transcription factors in myocardial cell gene expression. J Biol Chem. 1994; 269: 17772-5.
24. Allegra S, Li JY, Saez JM, Langlois D. Terminal differentiation of Sol 8 myoblasts is retarded by a transforming growth factor-beta autocrine regulatory loop. Biochem J. 2004; 381: 429-36.
25. Krainc D, Haas M, Ward DC, et al Assignment of human myocyte-specific enhancer binding factor 2C (hMEF2C) to human chromosome 5q14 and evidence that MEF2C is evolutionarily conserved. Genomics. 1995; 29: 809-11.
26. Chang SA, Lee EJ, Kang HJ, et al Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cells. 2008; 26: 1901-12.
27. Campbell JH, Efendy JL, Han C, et al Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. J Vasc Res. 2000; 37: 364-71.
28. Vranken I, De Visscher G, Lebacq A, et al The recruitment of primitive Lin(-) Sca-1(+), CD34(+), c-kit(+) and CD271(+) cells during the early intraperitoneal foreign body reaction. Biomaterials. 2008; 29: 797-808.
29. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med. 2004; 255: 320-31.
30. Limana F, Germani A, Zacheo A, et al Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res. 2005; 97: e73-83.
31. Germani A, Limana F, Capogrossi MC. Pivotal advances: high-mobility group box 1 protein-a cytokine with a role in cardiac repair. J Leukoc Biol. 2007; 81: 41-5.
32. Rossini A, Zacheo A, Mocini D, et al HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol. 2008; 44: 683-93.
33. Cho HJ, Kim TY, Park KW, et al The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. J Am Coll Cardiol. 2006; 48: 366-74.
34. Derval N, Barandon L, Dufourcq P, et al Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur J Cardiothorac Surg. 2008; 34: 248-54.